{
    "clinical_study": {
        "@rank": "92275", 
        "biospec_descr": {
            "textblock": "Blood Samples, Urine samples and Renal biopsy tissue samples."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The primary objectives of the study are as follows:  To develop and optimize a renal\n      functional magnetic resonance imaging (MRI) protocol consisting of Diffusion-Weighted\n      Magnetic Resonance Imaging (DW-MRI), Blood-Oxygen- Level-Dependent MRI (BOLD-MRI), Arterial\n      Spin Labeling MRI (ASL-MRI), Phase Contrast MRI (PC-MRI), and T1rho-MRI;  To compare renal\n      functional MRI cross-sectional readouts between normal healthy volunteers (NHV) and lupus\n      nephritis (LN) subjects.\n\n      The secondary objectives of this study are as follows: Explore whether renal functional MRI\n      techniques discriminate between renal inflammatory activity and damage in lupus nephritis\n      (LN); To examine whether renal functional MRI measurements correlate with laboratory\n      features of renal involvement and renal function in subjects with lupus nephritis (LN)."
        }, 
        "brief_title": "Functional MRI in Lupus Nephritis", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Lupus Nephritis", 
        "condition_browse": {
            "mesh_term": [
                "Lupus Nephritis", 
                "Nephritis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key Inclusion Criteria:\n\n          -  Must have a documented diagnosis of systemic lupus erythematosus (SLE) according to\n             current American Academy of Rheumatology (ACR) criteria. At least 4 American Academy\n             of Rheumatology (ACR) criteria must be documented, 1 of which must be a positive\n             antinuclear antibody (ANA), anti-Sm, or anti-double stranded DNA antibody.\n\n          -  Must have a standard of care renal biopsy for lupus nephritis performed or scheduled\n             within +/-7 days of Day 1.\n\n        Key Exclusion Criteria:\n\n          -  Has a metal device affected by magnetic resonance imaging (MRI )(e.g., any type of\n             electronic, mechanical, or magnetic implant; cardiac pacemaker; aneurysm clips;\n             implanted cardiac defibrillator), or has potential ferromagnetic foreign body (metal\n             slivers, metal shavings, other metal objects) that would be a contraindication for\n             magnetic resonance imaging (MRI).\n\n          -  History of renal transplant.\n\n          -  Subjects with uncontrolled diabetes or other condition that may result in significant\n             renal disease.\n\n        NOTE:  Other protocol-defined inclusion/exclusion criteria may apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Primary care clinic, community sample. 30 Normal Healthy Volunteers 30 Subjects with\n        documented diagnosis of Lupus Nephritis"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 8, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01731054", 
            "org_study_id": "999LE002"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "lupus nephritis", 
            "normal healthy volunteer", 
            "MRI"
        ], 
        "lastchanged_date": "January 31, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis", 
        "overall_contact": {
            "email": "clinicaltrials@biogenidec.com", 
            "last_name": "Biogen-Idec Investigator"
        }, 
        "overall_official": {
            "affiliation": "Biogen Idec", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "The test-retest reliability and sensitivity of renal functional magnetic resonance imaging (MRI) measurements to detect renal inflammatory activity or damage in normal healthy volunteers (NHV) and subjects with lupus nephritis (LN).", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "The mean difference between normal healthy volunteers (NHV) and lupus nephiritis (LN) groups in renal structural and functional magnetic resonance imaging (MRI) measurements.", 
                "safety_issue": "No", 
                "time_frame": "magnetic resonance imaging (MRI) within 7 days of renal biopsy"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01731054"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Correlation between histological renal activity and chronicity scores and renal functional magnetic resonance imaging (MRI) measurements in subjects with lupus nephritis (LN).", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Correlation between renal cortical volume and renal functional magnetic resonance imaging (MRI) measurements.", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Correlation between renal functional magnetic resonance imaging (MRI) measurements and renal function as assessed by estimated glomerular filtration rate (eGFR) using Modification of Diet in Renal Disease (MDRD) formula.", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Correlation between renal functional magnetic resonance imaging (MRI) measurements and proteinuria.", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }
        ], 
        "source": "Biogen Idec", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biogen Idec", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}